Home
/
CRISPR Therapeutics AG (CRSP)
Stock Analysis
CRISPR Therapeutics AG (CRSP)
CRSP · Healthcare • Biotech
52.61
+5.64%
TrendMixed
MomentumNeutral
52W Position32% of 52W range
Updated: 2026-06-16 12:02 UTC
WOI Investment Thesis
Mixed
TrendMixed
MomentumNeutral
FundamentalsStrong / Negative
ConfirmationPending
✓ Hold Above
52.57
✓ Break Above
53.01
✓ Watch Level
245.67
Risk Level
Elevated
Chart Scope
1Y Daily
Decision Levels
Resistance53.01
Support52.57
Breakout Levela clean close above 52.97 would strengthen the upside continuation case.
Invalidation LevelBelow 52.57
Upside Target—
Watch Level53.01
What's Driving CRSP?
📈 Technical recovery is improving
Momentum is Neutral. The main decision zone is framed by resistance near 53.01 and support near 52.57.
💼 Business quality remains relevant
The setup is supported by the latest fundamentals snapshot. Use the Business Lens card for revenue, profitability and balance sheet context.
⚠️ Key risk remains
Below 52.57
Full Analysis Workspace
Technical Setup
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 52.12 and resistance around 52.97. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Business Lens
Financial Snapshot
Source: sec
Financial Context
Financial context is mixed
🏢 Company
CRISPR Therapeutics AG
Note: This is an algorithmic technical snapshot, not financial advice.